EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Neurofilament light chain: A possible fluid biomarker in the intrahippocampal kainic acid mouse model for chronic epilepsy?

Marie-Laure Custers iD, Maxime Vande Vyver iD, Lea Kaltenböck, Kurt Barbé, Maria Bjerke, Ann Van Eeckhaut, Ilse Smolders

Epilepsia · 2023

DOI: 10.1111/epi.17669 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, 2023. Verfasst von Marie-Laure Custers und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pharmaceutical Chemistry, Drug Analysis, and Drug Information, Research Group Experimental Pharmacology, Vrije Universiteit Brussel, Br…. Hauptthemen laut MEDLINE: Ketamine, Epilepsy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fonds Wetenschappelijk Onderzoek.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

In the management of epilepsy, there is an ongoing quest to discover new biomarkers to improve the diagnostic process, the monitoring of disease progression, and the evaluation of treatment responsiveness. In this regard, biochemical traceability in biofluids is notably absent in contrast to other diseases. In the present preclinical study, we investigated the potential of neurofilament light chain (NfL) as a possible diagnostic and response fluid biomarker for epilepsy.

Methods

We gained insights into NfL levels during the various phases of the intrahippocampal kainic acid mouse model of temporal lobe epilepsy—namely, the status epilepticus (SE) and the chronic phase with spontaneous seizures. To this end, NfL levels were determined directly in the cerebral interstitial fluid (ISF) with cerebral open flow microperfusion as sampling technique, as well as in cerebrospinal fluid (CSF) and plasma. Lastly, we assessed whether NfL levels diminished upon curtailing SE with diazepam and ketamine.

Results

NfL levels are higher during SE in both cerebral ISF and plasma in kainic acid‐treated mice compared to sham‐injected mice. Additionally, ISF and plasma NfL levels are lower in mice treated with diazepam and ketamine to stop SE compared with the vehicle‐treated mice. In the chronic phase with spontaneous seizures, higher NfL levels could only be detected in ISF and CSF samples, and not in plasma. No correlations could be found between NfL levels and seizure burden, nor with immunohistological markers for neurodegeneration/inflammation. Significance Our findings demonstrate the translational potential of NfL as a blood‐based fluid biomarker for SE. This is less evident for chronic epilepsy, as in this case higher NfL levels could only be detected in ISF and CSF, and not in plasma, acknowledging the invasive nature of CSF sampling in chronic epilepsy follow‐up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KetamineEpilepsyAnimalsMiceKainic AcidIntermediate FilamentsNeurofilament ProteinsBiomarkersSeizuresDiazepam

Stichwörter der Autor:innen

cerebral open flow microperfusionfluid biomarkerkainic acidneurofilament light chaintemporal lobe epilepsy

Substanzen

Kainic AcidKetamineNeurofilament ProteinsBiomarkersDiazepam

Autor:innen und Institutionen

  • Laboratory of Pharmaceutical Chemistry, Drug Analysis, and Drug Information, Research Group Experimental Pharmacology, Vrije Universiteit Brussel, Brussels, Belgium.
  • Center for Neurosciences, Vrije Universiteit Brussel, Brussels, Belgium.
  • Department of Neurology, Universitair Ziekenhuis Brussel, Brussels, Belgium.
  • Research Group Biostatistics and Medical Informatics, Vrije Universiteit Brussel, Brussels, Belgium.
  • Department of Clinical Biology, Laboratory of Clinical Neurochemistry, Universitair Ziekenhuis Brussel, Brussels, Belgium.

ORCID-Profile: Marie-Laure Custers, Maxime Vande Vyver

Förderung

  • Fonds Wetenschappelijk Onderzoek

Zitieren

APA

Custers, M. L., Vande Vyver, M., Kaltenböck, L., Barbé, K., Bjerke, M., Van Eeckhaut, A., & Smolders, I. (2023). Neurofilament light chain: A possible fluid biomarker in the intrahippocampal kainic acid mouse model for chronic epilepsy?. Epilepsia. https://doi.org/10.1111/epi.17669

Vancouver

Custers ML, Vande Vyver M, Kaltenböck L, Barbé K, Bjerke M, Van Eeckhaut A, et al. Neurofilament light chain: A possible fluid biomarker in the intrahippocampal kainic acid mouse model for chronic epilepsy?. Epilepsia. 2023. doi:10.1111/epi.17669

BibTeX
@article{Custers2023,
  author = {Custers, Marie-Laure and Vande Vyver, Maxime and Kaltenböck, Lea and Barbé, Kurt and Bjerke, Maria and Van Eeckhaut, Ann and Smolders, Ilse},
  title = {Neurofilament light chain: A possible fluid biomarker in the intrahippocampal kainic acid mouse model for chronic epilepsy?},
  journal = {Epilepsia},
  year = {2023},
  doi = {10.1111/epi.17669}
}
Kostenlos starten →